How TZIELD is given
Everything to know about the TZIELD infusion process

TZIELD is a single, 14-day course of treatment
Given as an intravenous (IV) infusion
This means it's given through a needle into a vein in the arm
Once a day for 14 days
Infusions are administered by a healthcare team.* TZIELD COMPASS will check in throughout treatment to ensure a seamless experience
At least 30 minutes per infusion for age 8 years and up; at least 2 hours per infusion for ages 1–<8 years
Plus additional time before and after for preparation and monitoring
You have options for where and how to infuse
When it comes to location, be sure to share your preferences with your doctor, but note that some insurance plans do not cover all sites of care. Your doctor can also help you determine the best method of infusion for you or your loved one.
Work with your doctor to determine:
Your site of care
At an infusion center or doctor’s office
At home
A hybrid of both options
Your method of infusion
Daily IV infusion
Midline catheter
Peripherally inserted central catheter (PICC)
Download the Site of Care Guide to learn more about your location options.
TZIELD infusion process
Before infusion
Prep with your healthcare team:
- Talk with your doctor about which site of care option and infusion method is right for you or your loved one
- Discuss the timing of any recent or upcoming vaccinations with your doctor, as treatment with TZIELD may impact how well they work
- Confirm the dates, times, and locations of the infusions and discuss any additional questions you have
Connect with TZIELD COMPASS, which can:
- Help with infusion scheduling and coordinating travel logistics if needed
- Provide education and practical support for the infusion process
- Help connect you with a TZIELD Mentor if you're feeling nervous and want to talk to someone who's been through treatment
Discuss lab work and pre-infusion medications
- Your doctor will order testing for active viral infections (which can be life-threatening) of EBV and CMV before starting treatment
- Your doctor will order blood tests for you or your loved one to check. for active infections, verify your liver function and your complete blood counts
- If infusing at home, you may have to travel to a lab of your choice to complete lab work
- For the first 5 days of treatment, your healthcare provider will give medicines to be taken by mouth before starting the TZIELD infusion. These medicines include pain relievers (such as ibuprofen, naproxen or acetaminophen), an antihistamine, and possibly an anti-nausea medicine. These medicines may help reduce symptoms of CRS such as fever, headache, muscle and joint pain, or nausea, with or without vomiting. Vomiting and diarrhea may occur more frequently in children less than 8 years of age.
During infusion
Step 1
It's important to make sure you or your loved one are feeling well before beginning the infusion. A member of the healthcare team will check vitals, including temperature and blood pressure, and may also do a quick blood draw to check liver function and complete blood counts.
Step 2
The TZIELD dose is personalized based on height and weight and will gradually increase over the first 5 days to help the body adjust. The healthcare team will give you or your loved one oral medications before infusion to help reduce potential side effects. These could include certain types of pain relievers, antihistamines, and anti-nausea medication.
Step 3
Your healthcare team will then prepare the medicine and start the infusion. During treatment, they will check for serious side effects including signs of viral reactivation, as well as other side effects, and treat you as needed. Your healthcare team may temporarily or completely stop your treatment with TZIELD if you develop liver problems, have a serious infection, or if your blood counts stay too low.* Remember, if anything feels off or different to you or your loved one, let your healthcare team know—they're there to help.
Step 4
After the infusion is finished, the healthcare team will remove the IV or disconnect the midline or PICC line. You can expect a period of monitoring after the infusion to ensure there are no reactions, and then you'll be free to leave. You or your loved one should be able to continue the day, as advised by your doctor.
*For those who experience a decrease in white blood cell counts, levels typically begin to recover after the 5th day of treatment and return to pre-treatment levels within 2 weeks of completing infusions.
After infusion
Discuss with your doctor
- Your doctor will discuss the right post-treatment monitoring and care plan for you or your loved one including monitoring for signs and symptoms of viral reactivation after treatment for at least 2 months after the last infusion.
- Talk to your doctor or healthcare team about resuming activities post-treatment.
- Schedule regular check-ins with your doctor to keep track of your or your loved one's health over time.
Monitoring type 1 diabetes (T1D) going forward
It’s important to know and watch for early signs or symptoms of T1D (like increased thirst, frequent urination, or more tiredness than normal) and talk to your healthcare team about any changes you or your loved one experience.
Your doctor may recommend periodic lab tests or tools like glucose monitoring to help keep an eye on your or your loved one's blood sugar levels and to monitor for diabetic ketoacidosis (DKA), a medical emergency that happens when the body doesn’t have enough insulin, causing dangerous acids (called ketones) to build up in the blood.
Download the Infusion Guide to learn more about what to expect when treating with TZIELD
Make the most of your infusion experience
Explore helpful infusion tips below

You’re not alone
The TZIELD COMPASS Patient Support Program and the TZIELD Mentor Program are designed to guide and assist at every step of the treatment journey, making the TZIELD experience as seamless and supportive as possible.
Important Safety Information and Indication
What is the most important information I should know about TZIELD? TZIELD may cause serious side effects. These including:- Viral Reactivation. Epstein-Barr virus (EBV) and cytomegalovirus (CMV) are common viruses that may stay inactive in your body after an initial infection. TZIELD may cause these viruses to become active again which, especially in patients with a weakened immune system, can become serious and potentially life-threatening. These viral reactivations can happen during treatment with TZIELD and up to 2 months after your last dose. Your healthcare provider will test you for active EBV and CMV infections before treatment with TZIELD. Contact your healthcare provider right away if you develop symptoms of an infection during or after treatment with TZIELD (such as fever, swollen glands, or fatigue).
- Cytokine release syndrome (CRS). Signs and symptoms may start during the first 5 days of TZIELD treatment and could include fever, nausea (with or without vomiting), feeling tired (fatigue), headache, muscle and joint pain, or increased liver enzymes in your blood. Tell your healthcare provider right away if you develop any signs and symptoms of CRS during treatment with TZIELD.
- Decrease in white blood cells. TZIELD may cause a decrease in a type of white blood cell called lymphocytes. A decrease in white blood cells is a serious, but common side effect that can affect your body’s ability to fight infections. A decrease in white blood cell counts can happen after your first dose. Your white blood cell counts will start to go back to normal after your fifth dose of TZIELD. Some people may develop longer and more severe decreases in lymphocytes.
Your healthcare provider will do blood tests to check for active infections, verify your liver function and your complete blood counts before you start treatment and during treatment with TZIELD. During and after your treatment with TZIELD, your healthcare provider will check for serious side effects, as well as other side effects, and treat you as needed. Your healthcare provider may temporarily or completely stop your treatment with TZIELD, if you develop liver problems, have a serious infection or viral reactivation, or if your blood counts stay too low.
What should I tell my healthcare provider before receiving TZIELD? Before or after receiving TZIELD, tell your healthcare provider about all your medical conditions, including if you:- have any of the conditions or symptoms listed in the section “What is the most important information I should know about TZIELD?”
- have a weakened immune system, including if you have Down syndrome.
- have a serious infection or an infection that does not go away or keeps coming back (chronic).
- have recently received or are scheduled to receive an immunization (vaccine). TZIELD may affect how well a vaccine works. Tell your healthcare provider that you are receiving treatment with TZIELD before receiving a vaccine.
- are pregnant or plan to become pregnant. TZIELD may harm your unborn baby. Do not receive TZIELD during pregnancy and at least 30 days before a planned pregnancy.
If you become pregnant while taking TZIELD, you are encouraged to report your pregnancy to us at our Adverse Event reporting line at 1-800-633-1610 or visit https://ae.reporting.sanofi.
- are breastfeeding or plan to breastfeed. It is not known if TZIELD passes into your breast milk and if it can harm your baby. Talk to your healthcare provider about the best way to feed your baby if you receive TZIELD.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
What are the possible side effects of TZIELD? The most common side effects of TZIELD include:- decrease in white blood cell counts
- vomiting
- rash
- diarrhea
- headache
These are not all of the possible side effects of TZIELD. For more information, ask your healthcare provider or pharmacist. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088. You may also report side effects to us at 1-800-633-1610 or www.fda.gov/medwatch or 1-800-FDA-1088.
Please see full Prescribing Information, including Risk of SERIOUS SIDE EFFECTS and Medication Guide.
What is TZIELD?
TZIELD is a prescription medicine used to delay the onset of Stage 3 type 1 diabetes, which is when your body cannot make enough insulin on its own and may require insulin injections. TZIELD is for adults and children 1 year of age and older who have Stage 2 type 1 diabetes. This means that they have tested positive for 2 or more type 1 diabetes-related autoantibodies, have abnormal blood sugar levels, and do not have type 2 diabetes or other forms of diabetes.
It is not known if TZIELD is safe and effective in children under 1 years of age.
Important Safety Information and Indication
- Viral Reactivation. Epstein-Barr virus (EBV) and cytomegalovirus (CMV) are common viruses that may stay inactive in your body after an initial infection. TZIELD may cause these viruses to become active again which, especially in patients with a weakened immune system, can become serious and potentially life-threatening. These viral reactivations can happen during treatment with TZIELD and up to 2 months after your last dose. Your healthcare provider will test you for active EBV and CMV infections before treatment with TZIELD. Contact your healthcare provider right away if you develop symptoms of an infection during or after treatment with TZIELD (such as fever, swollen glands, or fatigue).
- Cytokine release syndrome (CRS). Signs and symptoms may start during the first 5 days of TZIELD treatment and could include fever, nausea (with or without vomiting), feeling tired (fatigue), headache, muscle and joint pain, or increased liver enzymes in your blood. Tell your healthcare provider right away if you develop any signs and symptoms of CRS during treatment with TZIELD.
- Decrease in white blood cells. TZIELD may cause a decrease in a type of white blood cell called lymphocytes. A decrease in white blood cells is a serious, but common side effect that can affect your body’s ability to fight infections. A decrease in white blood cell counts can happen after your first dose. Your white blood cell counts will start to go back to normal after your fifth dose of TZIELD. Some people may develop longer and more severe decreases in lymphocytes.
Your healthcare provider will do blood tests to check for active infections, verify your liver function and your complete blood counts before you start treatment and during treatment with TZIELD. During and after your treatment with TZIELD, your healthcare provider will check for serious side effects, as well as other side effects, and treat you as needed. Your healthcare provider may temporarily or completely stop your treatment with TZIELD, if you develop liver problems, have a serious infection or viral reactivation, or if your blood counts stay too low.
What should I tell my healthcare provider before receiving TZIELD? Before or after receiving TZIELD, tell your healthcare provider about all your medical conditions, including if you:- have any of the conditions or symptoms listed in the section “What is the most important information I should know about TZIELD?”
- have a weakened immune system, including if you have Down syndrome.
- have a serious infection or an infection that does not go away or keeps coming back (chronic).
- have recently received or are scheduled to receive an immunization (vaccine). TZIELD may affect how well a vaccine works. Tell your healthcare provider that you are receiving treatment with TZIELD before receiving a vaccine.
- are pregnant or plan to become pregnant. TZIELD may harm your unborn baby. Do not receive TZIELD during pregnancy and at least 30 days before a planned pregnancy.
If you become pregnant while taking TZIELD, you are encouraged to report your pregnancy to us at our Adverse Event reporting line at 1-800-633-1610 or visit https://ae.reporting.sanofi.
- are breastfeeding or plan to breastfeed. It is not known if TZIELD passes into your breast milk and if it can harm your baby. Talk to your healthcare provider about the best way to feed your baby if you receive TZIELD.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
What are the possible side effects of TZIELD? The most common side effects of TZIELD include:- decrease in white blood cell counts
- vomiting
- rash
- diarrhea
- headache
These are not all of the possible side effects of TZIELD. For more information, ask your healthcare provider or pharmacist. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088. You may also report side effects to us at 1-800-633-1610 or www.fda.gov/medwatch or 1-800-FDA-1088.
Please see full Prescribing Information, including Risk of SERIOUS SIDE EFFECTS and Medication Guide.
What is TZIELD?
TZIELD is a prescription medicine used to delay the onset of Stage 3 type 1 diabetes, which is when your body cannot make enough insulin on its own and may require insulin injections. TZIELD is for adults and children 1 year of age and older who have Stage 2 type 1 diabetes. This means that they have tested positive for 2 or more type 1 diabetes-related autoantibodies, have abnormal blood sugar levels, and do not have type 2 diabetes or other forms of diabetes.
It is not known if TZIELD is safe and effective in children under 1 years of age.